The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients

AuthorFarzad Shidfar
AuthorShima Seyyed Ebrahimi
AuthorSharieh Hosseini
AuthorIraj Heydari
AuthorShahrzad Shidfar
AuthorGiti Hajhassani
Accessioned Date2023-12-27T09:12:25Z
Available Date2023-12-27T09:12:25Z
Issued Date2012-04-30
AbstractType 2 diabetes is a well-known endocrine and metabolic disorder which has reached epidemic proportions worldwide and represents a serious public health concern. Hyperglycemia and dyslipidemia are two major abnormalities which are major cardiovascular risk factors. Berberine is a major alkaloid in Berberis vulgaris fruit extract (BVFE) which have important role in regulation of serum glucose and fat metabolism in-vivo and in-vitro but its role in type 2 diabetes have not been extensively examined.
DOIhttps://doi.org/10.22037/ijpr.2012.1155
URIhttps://repository.brieflands.com/handle/123456789/56511
KeywordBerberis vulgaris
KeywordDiabetes
KeywordApoB
KeywordApoA-I
KeywordAntioxidant
KeywordLipoproteins
PublisherBrieflands
TitleThe Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients
TypeOriginal Article_imported
Files